MedLife S.A. Logo

MedLife S.A.

ISIN: ROMEDLACNOR6 | Ticker: M | LEI: 254900RJWPQ4SLGCPI85
Sector: Health CareSub-Industry: Health Care Distributors
Country: Romania

About MedLife S.A.

Company Description

MedLife is the largest private healthcare provider in Romania. The company operates the widest network of clinics, one of the large networks of medical laboratories, general and specialised hospitals and it has the largest client database for Healthcare Prevention Packages in the country. In addition, from the standpoint of sales, it is one of the largest private healthcare companies in Central and Eastern Europe, according to the public information available to MedLife Group.

Year founded

1996

Served area

Romania

Headquarters

Calea Grivitei, Nr. 365, 010718 Bucharest – Romania

Financial statements

Download as Excel
Line item in (ron) 01.01.2020 02.01.2020 01.01.2021 02.01.2021 01.01.2022 01.01.2023
Assets N/A N/A 1,183,493,863.00 N/A 1,417,602,227.00 2,151,976,329.00
Noncurrent Assets N/A N/A 904,446,206.00 N/A 1,034,769,069.00 1,686,590,024.00
Property Plant And Equipment N/A N/A 535,672,488.00 N/A 552,206,613.00 828,501,060.00
Goodwill N/A N/A 147,256,824.00 N/A 199,679,613.00 368,672,606.00
Intangible Assets Other Than Goodwill N/A N/A 46,755,678.00 N/A 60,556,655.00 100,192,265.00
Other Noncurrent Financial Assets N/A N/A 27,940,022.00 N/A 31,610,586.00 82,810,704.00
Current Assets N/A N/A 279,047,657.00 N/A 382,833,158.00 465,386,305.00
Inventories N/A N/A 53,058,518.00 N/A 74,229,585.00 98,770,370.00
Cash and cash equivalents 37,688,896.00 N/A 81,970,397.00 N/A 135,858,888.00 89,068,154.00
Equity And Liabilities N/A N/A 1,183,493,863.00 N/A 1,417,602,227.00 2,151,976,329.00
Equity N/A 206,898,601.00 268,906,545.00 268,906,545.00 381,404,558.00 482,038,245.00
Retained Earnings N/A N/A 35,701,579.00 N/A 122,394,796.00 131,596,255.00
Treasury Shares N/A N/A 666,624.00 N/A 4,015,977.00 3,219,219.00
Other Reserves N/A N/A 124,211,557.00 N/A 137,335,499.00 204,591,242.00
Equity Attributable To Owners Of Parent N/A N/A 241,273,524.00 N/A 338,109,409.00 416,780,834.00
Noncontrolling Interests N/A N/A 27,633,021.00 N/A 43,295,149.00 65,257,411.00
Liabilities N/A N/A 914,587,318.00 N/A 1,036,197,669.00 1,669,938,084.00
Noncurrent Liabilities N/A N/A 600,259,314.00 N/A 621,631,741.00 1,094,356,436.00
Deferred Tax Liabilities N/A N/A 20,345,799.00 N/A 23,559,617.00 44,250,160.00
Longterm Borrowings N/A N/A 414,696,592.00 N/A 440,840,484.00 803,273,659.00
Current Liabilities N/A N/A 314,328,004.00 N/A 414,565,928.00 575,581,648.00
Current Provisions N/A N/A 7,209,494.00 N/A 7,992,337.00 9,783,326.00
Trade And Other Current Payables N/A N/A 151,690,134.00 N/A 224,242,318.00 335,356,742.00
Current Tax Liabilities Current N/A N/A 5,467,450.00 N/A 1,467,625.00 814,508.00
Line item in (ron) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Other Revenue 9,274,762.00 10,362,989.00 14,118,061.00
Revenue From Contracts With Customers 1,077,448,351.00 1,427,218,373.00 1,795,432,748.00
Cost Of Merchandise Sold 35,649,736.00 106,225,169.00 209,975,320.00
Wages And Salaries 277,035,208.00 333,837,004.00 442,897,905.00
Social Security Contributions 10,767,730.00 12,214,486.00 15,852,088.00
Depreciation And Amortisation Expense 102,897,388.00 113,760,199.00 152,410,751.00
Profit Loss From Operating Activities 109,111,128.00 171,851,903.00 94,229,672.00
Finance Costs 23,252,552.00 27,451,079.00 42,489,150.00
Profit Loss Before Tax 78,551,159.00 135,419,561.00 49,557,301.00
Income Tax Expense Continuing Operations 14,787,475.00 22,506,352.00 12,124,746.00
Profit (loss) 63,763,684.00 112,913,209.00 37,432,555.00
Profit Loss Attributable To Owners Of Parent 56,702,860.00 102,613,932.00 32,173,072.00
Profit Loss Attributable To Noncontrolling Interests 7,060,824.00 10,299,277.00 5,259,483.00
Line item in (ron) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 63,763,684.00 112,913,209.00 37,432,555.00
Adjustments For Decrease Increase In Inventories N/A -9,968,002.00 -5,902,852.00 -12,198,174.00
Adjustments For Increase Decrease In Trade Account Payable N/A -19,743,767.00 8,752,697.00 31,216,630.00
Adjustments For Depreciation And Amortisation Expense N/A 102,897,388.00 113,760,199.00 152,410,751.00
Adjustments For Provisions N/A 5,460,306.00 782,843.00 625,545.00
Adjustments For Unrealised Foreign Exchange Losses Gains N/A 7,392,342.00 9,076,658.00 3,501,567.00
Cash Flows From Used In Operations N/A 160,536,264.00 282,624,716.00 228,563,610.00
Interest Paid Classified As Operating Activities N/A 22,207,210.00 28,820,100.00 32,377,399.00
Interest Received Classified As Operating Activities N/A 50,893.00 149,944.00 1,261,843.00
Income Taxes Paid Refund Classified As Operating Activities N/A 9,716,112.00 26,557,162.00 12,832,118.00
Cash Flows From Used In Operating Activities N/A 128,663,835.00 227,397,398.00 184,615,936.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 23,769,813.00 52,504,735.00 316,554,749.00
Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities N/A 0.00 1,661,990.00 N/A
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 83,116,171.00 91,525,535.00 149,107,846.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 5,962,689.00 5,385,050.00 20,243,591.00
Cash Flows From Used In Investing Activities N/A -112,848,673.00 -149,415,320.00 -485,906,186.00
Payments From Changes In Ownership Interests In Subsidiaries N/A N/A 1,661,990.00 6,527,676.00
Payments To Acquire Or Redeem Entitys Shares N/A 3,548,879.00 3,669,570.00 7,851,825.00
Proceeds From Borrowings Classified As Financing Activities N/A 101,692,813.00 84,203,084.00 411,844,392.00
Repayments Of Borrowings Classified As Financing Activities N/A 25,118,546.00 56,241,155.00 73,446,528.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 43,857,062.00 46,653,956.00 69,381,986.00
Dividends Paid Classified As Financing Activities N/A 701,987.00 70,000.00 136,861.00
Cash Flows From Used In Financing Activities N/A 28,466,339.00 -24,093,587.00 254,499,516.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A 44,281,501.00 53,888,491.00 -46,790,734.00
Cash and cash equivalents 37,688,896.00 81,970,397.00 135,858,888.00 89,068,154.00

Please note that some sums might not add up.

Filings & Publications

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / RUM
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

ROMEDLACNOR6

LEI

254900RJWPQ4SLGCPI85

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Providers & Services

Sub-Industry

Health Care Distributors

Listed Stock Exchange

Bucharest Stock Exchange

Stock Index

BET

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.